NCT06401356 An Extension Study for Patients Previously Enrolled in Studies With Pelabresib Status RECRUITING Phase PHASE3
NCT06392763 Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data Status COMPLETED Phase N/A
NCT06388941 Iptacopan in Patients With ANCA Associated Vasculitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06388668 Lipid Testing After Myocardial Infarction at the Montreal Heart Institute Status RECRUITING Phase N/A
NCT06386419 A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia Status COMPLETED Phase PHASE4
NCT06379217 NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06376253 A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Status TERMINATED Phase PHASE1
NCT06372925 Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction Status RECRUITING Phase PHASE4
NCT06345157 ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06337617 A Multi-center Retrospective Study With Secondary Use of Data of Tafinlar (Dabrafenib) Plus Mekinist (Trametinib) in Chinese Patients With BRAF V600 Mutation Positive Melanoma Status COMPLETED Phase N/A
NCT06335979 An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). Status RECRUITING Phase PHASE1
NCT06331312 Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06311383 A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment Status COMPLETED Phase N/A
NCT06308588 Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT06293365 Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06288113 Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial Status RECRUITING Phase PHASE2
NCT06275724 Specified Drug-use Survey of Leqvio for s.c. Injection. Status ACTIVE_NOT_RECRUITING Phase N/A